BB Biotech AG 13D and 13G filings for Molecular Templates, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:13 pm Purchase | 2022-12-31 | 13G | Molecular Templates, Inc. MTEM | BB Biotech AG | 746,134 19.900% | 26,667 (+3.71%) | Filing |
| 2022-02-11 4:49 pm Purchase | 2021-12-31 | 13G | Molecular Templates, Inc. MTEM | BB Biotech AG | 719,467 19.200% | 83,292 (+13.09%) | Filing |
| 2021-04-26 1:11 pm Purchase | 2021-04-07 | 13G | Molecular Templates, Inc. MTEM | BB Biotech AG | 636,175 17.000% | 210,819 (+49.56%) | Filing |
| 2021-02-12 5:07 pm Purchase | 2020-12-31 | 13G | Molecular Templates, Inc. MTEM | BB Biotech AG | 425,355 12.800% | 76,689 (+21.99%) | Filing |
| 2020-11-03 5:33 pm Purchase | 2020-10-26 | 13G | Molecular Templates, Inc. MTEM | BB Biotech AG | 348,666 10.500% | 204,590 (+142.00%) | Filing |